SCHEDULE 13G/A
Statement of Beneficial Ownership
Stoke Therapeutics, Inc. Filed Acc 0000895421-25-000200
Loading xslSCHEDULE_13G_X01/primary_doc.xml…
Stoke Therapeutics, Inc. Filed Acc 0000895421-25-000200
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…